Physician profile
Daniel S Miller
NPI 1427098466
$1,857.67
in general payments reported to CMS, 2019-2025
16 companies · $374 in 2025
The $374 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.69 · 2020: $107 · 2021: $225 · 2022: $339 · 2023: $354 · 2024: $413 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,140.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $710.72 | 2022-2025 | |
| Alcon Vision LLC | $221.51 | 2020-2025 | Tryptyr, Hydrus Microstent |
| Allergan, INC. | $168.46 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $157.18 | 2019-2025 | Eylea Hd, Eylea |
| Oyster Point Pharma, INC. | $104.73 | 2022-2024 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $104.22 | 2024-2025 | Xdemvy |
| Biogen, INC. | $103.54 | 2022-2024 | Byooviz |
| Novartis Pharmaceuticals Corporation | $60.30 | 2020-2023 | |
| Aerie Pharmaceuticals, INC. | $48.30 | 2020-2021 | |
| Bausch & Lomb Americas INC. | $46.41 | 2024-2025 | Miebo, Xiidra |
| Sun Pharmaceutical Industries INC. | $37.79 | 2021 | |
| Astellas Pharma US INC | $29.61 | 2024 | Izervay |
| Rxsight INC | $24.09 | 2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Genentech USA, INC. | $15.21 | 2022 | |
| Harrow Eye, LLC | $13.82 | 2024 | Iheezo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $11.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.